Seres Therapeutics, Inc. (MCRB)
NASDAQ: MCRB · Real-Time Price · USD
0.724
-0.090 (-11.09%)
Nov 21, 2024, 3:29 PM EST - Market open
Seres Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | - | -113.72 | -250.16 | -65.58 | -89.13 | -70.28 | Upgrade
|
| Depreciation & Amortization | - | 15.14 | 11.83 | 5.95 | 6.58 | 7.6 | Upgrade
|
| Other Amortization | - | 1.14 | 0.71 | 2.53 | 0.55 | 0.28 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | - | - | 0.1 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | -0.24 | 0.69 | 0.5 | 0.45 | -0.17 | Upgrade
|
| Stock-Based Compensation | - | 34.1 | 25.48 | 20.22 | 8.82 | 8.34 | Upgrade
|
| Other Operating Activities | - | 5.2 | 1.03 | 1.54 | 2.32 | 2.23 | Upgrade
|
| Change in Accounts Receivable | - | -8.67 | - | 9.39 | -7.6 | -1.79 | Upgrade
|
| Change in Inventory | - | -29.65 | - | - | - | - | Upgrade
|
| Change in Accounts Payable | - | -11.58 | 2.2 | 9.36 | -1.16 | -1.46 | Upgrade
|
| Change in Unearned Revenue | - | 6.41 | -7.13 | -4.36 | -11.57 | -17.52 | Upgrade
|
| Change in Other Net Operating Assets | - | -15.48 | -13.47 | 27.14 | -2.87 | -3.86 | Upgrade
|
| Operating Cash Flow | - | -117.35 | -228.82 | 6.69 | -93.61 | -76.52 | Upgrade
|
| Capital Expenditures | - | -7.98 | -9.82 | -9.57 | -0.59 | -1 | Upgrade
|
| Investment in Securities | - | 18.56 | 92.25 | 73.65 | -158.3 | -29.52 | Upgrade
|
| Investing Cash Flow | - | 10.58 | 82.43 | 64.09 | -158.89 | -30.52 | Upgrade
|
| Long-Term Debt Issued | - | 103.38 | 27.61 | - | - | 25 | Upgrade
|
| Long-Term Debt Repaid | - | -52.86 | -1.91 | -0.95 | - | - | Upgrade
|
| Net Debt Issued (Repaid) | - | 50.52 | 25.7 | -0.95 | - | 25 | Upgrade
|
| Issuance of Common Stock | - | 21.19 | 103.9 | 2.13 | 303.42 | 61.66 | Upgrade
|
| Other Financing Activities | - | - | - | - | - | -0.43 | Upgrade
|
| Financing Cash Flow | - | 71.71 | 129.6 | 1.18 | 303.42 | 86.23 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | 0 | -0 | -0 | - | - | Upgrade
|
| Net Cash Flow | - | -35.07 | -16.79 | 71.95 | 50.92 | -20.81 | Upgrade
|
| Free Cash Flow | - | -125.33 | -238.64 | -2.88 | -94.2 | -77.52 | Upgrade
|
| Free Cash Flow Margin | - | -99.21% | -3347.88% | -1.99% | -283.61% | -224.67% | Upgrade
|
| Free Cash Flow Per Share | - | -0.98 | -2.21 | -0.03 | -1.18 | -1.37 | Upgrade
|
| Cash Interest Paid | - | 12.55 | 4.93 | 2.45 | 2.45 | 0.22 | Upgrade
|
| Levered Free Cash Flow | - | -56.9 | -124.23 | 14.04 | -52.03 | -28.11 | Upgrade
|
| Unlevered Free Cash Flow | - | -49.8 | -121.18 | 13.34 | -50.75 | -28.08 | Upgrade
|
| Change in Net Working Capital | -21.92 | 23.58 | -5.39 | -37.04 | 10.48 | -0.97 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.